A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group,Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) Save

Date Added
November 14th, 2017
PRO Number
Pro00058455
Researcher
Ricardo Arbizu alvarez

Silhouette
Keywords
Bowel, Drug Studies, Pediatrics
Summary

The purpose of this study is to find out if the drug linaclotide works and is safe. The study will compare linaclotide with placebo in children 12 - 17 years of age using the approved adult dose compared with placebo in pediatric patients 6 to 17 years of age who fulfill modified Rome III criteria for child/adolescent functional
constipation (FC).

Institution
MUSC
Recruitment Contact
Kalyan Chundru
843-792-1213
choudhar@musc.edu

Change_preferences

-- OR --

Create_login